Novo's Wegovy pill has had a strong start in the weight-loss market, with a significant number of prescriptions filled in its debut week. The pill has been approved in the EU and has shown encouraging early uptake, with some outlets reporting over 18,000 US prescriptions. The launch is part of a larger competition in the weight-loss drug market, with other companies, including Lilly, also vying for market share.